New drug safety check: how does anaprazole affect liver, kidney, and elderly patients?
NCT ID NCT07345689
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the drug anaprazole sodium is processed by the body and whether it is safe for people with liver or kidney issues, as well as for older adults. About 60 participants will be enrolled to measure drug levels and track any side effects. The goal is to understand how these special populations handle the drug compared to healthy individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- What does life feel like for children with a rare birth defect? a new study asks
- Iron deficiency hidden by inflammation: a new test may see through it
- AI model aims to predict heart risks after hip surgery in seniors
- Liver function and drug dosing: a closer look at ulonivirine
- Liver function may change how mavorixafor works in the body